More about Universal Health Services, Inc.
Regulatory Filings for Universal Health Services, Inc.
Fundamentals for Universal Health Services, Inc.
From AI Euphoria to Energy Fear: The Market‘s Pivot as Middle East Conflict Reshapes Portfolios
From AI Adoption Surge to Capex Scrutiny: Volatility Risks Loom for U.S. Financial Markets
Airlines and Tourism Stocks Face Pressure as Global Risks Escalate
Fundamentals for Universal Health Services, Inc.
Business Operations:
Sector: HealthcareIndustry: Medical Care Facilities
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Revenue projections:
UHS is projected to see lower revenues than in the previous year, a trend that usually concerns investors. Declining revenues often harm a company's profitability, leading investors to exercise caution as they weigh the potential risks of continued financial downturns.
Financial Ratios:
| currentRatio | 1.393000 |
|---|---|
| forwardPE | 10.859663 |
| debtToEquity | 76.373000 |
| earningsGrowth | 0.583000 |
| revenueGrowth | 0.112000 |
| grossMargins | 0.417160 |
| operatingMargins | 0.096940 |
| trailingEps | 15.010000 |
| forwardEps | 18.160000 |
UHS's current ratio being 1.393 shows it has more than enough assets to cover its short-term debts. The company's liquidity position is strong, with ample cash reserves available to meet its immediate financial obligations without strain.
UHS's Forward PE ratio is favorable, meaning the stock price aligns well with earnings and isn't overvalued. This allows room for growth, making it an attractive investment for those seeking potential upside while ensuring the stock is not overpriced.
With positive earnings and revenue growth, Universal Health Services, Inc. is on a path to expand its business. This strong financial performance suggests the company will continue to grow, as increasing profits and revenue highlight a healthy outlook.
With a forward EPS greater than its trailing EPS, Universal Health Services, Inc. is expected to see higher profitability this year. The forecasted increase in earnings reflects optimism about the company's financial growth and potential for improved performance over the prior year.
Price projections:
Universal Health Services, Inc.'s price projections have consistently been revised higher, indicating growing confidence in the company's future potential. Analysts appear more optimistic about Universal Health Services, Inc.'s ability to generate strong results going forward.
Recommendation changes over time:
Analysts are favoring Universal Health Services, Inc. with a buy bias, highlighting the stock's potential as a solid investment. This recommendation might drive more investors to consider Universal Health Services, Inc. as a secure and profitable option for their money, contributing to a broader positive sentiment in the market.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst technicals.
Latest Regulatory Filings for SP5
Companies with the best and the worst fundamentals.
Retailers at a Crossroads: Analyzing the Shift to Value in January Sales
Corporate Governance in the Crosshairs: SEC Policy Shifts and the Litigation Wave